Globally nonalcoholic fatty liver disease is the most common chronic liver disease known to date. Symptoms include significant fat build up in and around the liver without a history of alcohol abuse. The condition is also known as steatosis or steatohepatitis.
Rated 1.7 / 5 (How Ratings Work)
Possibility of efficacy for cannabis in treatment of fatty liver disease (non-alcoholic) aka (steatosis).
Based on 3 Studies from 2009 - 2017
Study Name, Description & Year
Rating
Beta-caryophyllene Protects Against Alcoholic Steatohepatitis By Attenuating Inflammation And Metabolic Dysregulation In Mice
Animal study (mice) — 2017
β-Caryophyllene Attenuates Palmitate-induced Lipid Accumulation Through AMPK Signaling By Activating CB2 Receptor In Human HepG2 Hepatocytes
Laboratory test — 2016
Cannabidiol Ameliorates Cognitive And Motor Impairments In Mice With Bile Duct Ligation
Animal study (mice) — 2009